Last reviewed · How we verify

NCT07093853

Mandibular Overdentures Retained by Four Locator Attachments Versus Four-Implant Bar Attachments

Recruiting now Last updated 30 July 2025
What this trial tests

trial testing Four Locator Attachments, Four Bar Attachment System in Bone Loss in 22 participants. Currently enrolling.

Timeline
1 January 2024
Primary endpoint
1 August 2025
1 October 2025

Quick facts

Lead sponsorMenoufia University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment22
Start date1 January 2024
Primary completion1 August 2025
Estimated completion1 October 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Menoufia University

Who can join

Adults 40 to 70, any sex, with Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This 10-year retrospective study investigates residual ridge changes in edentulous patients treated with mandibular overdentures (ODs) retained by either four Locator attachments or a four-implant bar system. Although two-implant ODs are well established, four-implant configurations may offer enhanced stability and function. Locator and bar attachments are commonly used, but their long-term effects on bone resorption patterns-especially posterior mandibular and anterior maxillary resorption-remain unclear. By standardizing implant positions, this study aims to directly compare the two systems to help guide clinicians in selecting the most effective attachment type for long-term success.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bone Loss

Currently open trials in the same condition.

Other Menoufia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07093853.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing